Retrospective External Validation of the Status Epilepticus Severity Score (STESS) to Predict In-hospital Mortality in Adults with Nonhypoxic Status Epilepticus: A Machine Learning Analysis.


Journal

Neurocritical care
ISSN: 1556-0961
Titre abrégé: Neurocrit Care
Pays: United States
ID NLM: 101156086

Informations de publication

Date de publication:
04 2023
Historique:
received: 24 03 2022
accepted: 09 09 2022
medline: 13 4 2023
pubmed: 14 10 2022
entrez: 13 10 2022
Statut: ppublish

Résumé

The objective of this study was to validate the value of the Status Epilepticus Severity Score (STESS) in the prediction of the risk of in-hospital mortality in patients with nonhypoxic status epilepticus (SE) using a machine learning analysis. We included consecutive patients with nonhypoxic SE (aged ≥ 16 years) admitted from 2013 to 2021 at the Modena Academic Hospital. A decision tree analysis was performed using in-hospital mortality as a dependent variable and the STESS predictors as input variables. We evaluated the accuracy of STESS in predicting in-hospital mortality using the area under the receiver operating characteristic curve (AUROC) with 95% confidence interval (CI). Among 629 patients with SE, the in-hospital mortality rate was 23.4% (147 of 629). The median STESS in the entire cohort was 2.9 (SD 1.6); it was lower in surviving compared with deceased patients (2.7, SD 1.5 versus 3.9, SD 1.6; p < 0.001). Of deceased patients, 82.3% (121 of 147) had scores of 3-6, whereas 17.7% (26 of 147) had scores of 0-2 (p < 0.001). STESS was accurate in predicting mortality, with an AUROC of 0.688 (95% CI 0.641-0.734) only slightly reduced after bootstrap resampling. The most significant predictor was the seizure type, followed by age and level of consciousness at SE onset. Nonconvulsive SE in coma and age ≥ 65 years predicted a higher risk of mortality, whereas generalized convulsive SE and age < 65 years were associated with a lower risk of death. The decision tree analysis using STESS variables correctly classified 90% of survivors and 34% of nonsurvivors after the SE, with an overall risk of error of 23.1%. This validation study using a machine learning system showed that STESS is a valuable prognostic tool. The score appears particularly accurate and effective in identifying patients who are alive at discharge (high negative predictive value), whereas it has a lower predictive value for in-hospital mortality.

Sections du résumé

BACKGROUND
The objective of this study was to validate the value of the Status Epilepticus Severity Score (STESS) in the prediction of the risk of in-hospital mortality in patients with nonhypoxic status epilepticus (SE) using a machine learning analysis.
METHODS
We included consecutive patients with nonhypoxic SE (aged ≥ 16 years) admitted from 2013 to 2021 at the Modena Academic Hospital. A decision tree analysis was performed using in-hospital mortality as a dependent variable and the STESS predictors as input variables. We evaluated the accuracy of STESS in predicting in-hospital mortality using the area under the receiver operating characteristic curve (AUROC) with 95% confidence interval (CI).
RESULTS
Among 629 patients with SE, the in-hospital mortality rate was 23.4% (147 of 629). The median STESS in the entire cohort was 2.9 (SD 1.6); it was lower in surviving compared with deceased patients (2.7, SD 1.5 versus 3.9, SD 1.6; p < 0.001). Of deceased patients, 82.3% (121 of 147) had scores of 3-6, whereas 17.7% (26 of 147) had scores of 0-2 (p < 0.001). STESS was accurate in predicting mortality, with an AUROC of 0.688 (95% CI 0.641-0.734) only slightly reduced after bootstrap resampling. The most significant predictor was the seizure type, followed by age and level of consciousness at SE onset. Nonconvulsive SE in coma and age ≥ 65 years predicted a higher risk of mortality, whereas generalized convulsive SE and age < 65 years were associated with a lower risk of death. The decision tree analysis using STESS variables correctly classified 90% of survivors and 34% of nonsurvivors after the SE, with an overall risk of error of 23.1%.
CONCLUSIONS
This validation study using a machine learning system showed that STESS is a valuable prognostic tool. The score appears particularly accurate and effective in identifying patients who are alive at discharge (high negative predictive value), whereas it has a lower predictive value for in-hospital mortality.

Identifiants

pubmed: 36229575
doi: 10.1007/s12028-022-01610-3
pii: 10.1007/s12028-022-01610-3
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

254-262

Informations de copyright

© 2022. Springer Science+Business Media, LLC, part of Springer Nature and Neurocritical Care Society.

Références

Trinka E, Cock H, Hesdorffer D, et al. A definition and classification of status epilepticus–report of the ILAE task force on classification of status epilepticus. Epilepsia. 2015;56(10):1515–23. https://doi.org/10.1111/epi.13121 .
doi: 10.1111/epi.13121 pubmed: 26336950
Leitinger M, Trinka E, Zimmermann G, Granbichler CA, Kobulashvili T, Siebert U. Epidemiology of status epilepticus in adults: apples, pears, and oranges - a critical review. Epilepsy Behav. 2020;103(Pt A): 106720. https://doi.org/10.1016/j.yebeh.2019.106720 .
doi: 10.1016/j.yebeh.2019.106720 pubmed: 31902646
Neligan A, Shorvon SD. Frequency and prognosis of convulsive status epilepticus of different causes: a systematic review. Arch Neurol. 2010;67(8):931–40. https://doi.org/10.1001/archneurol.2010.169 .
doi: 10.1001/archneurol.2010.169 pubmed: 20697043
Giovannini G, Monti G, Tondelli M, et al. Mortality, morbidity and refractoriness prediction in status epilepticus: comparison of STESS and EMSE scores. Seizure. 2017;46:31–7. https://doi.org/10.1016/j.seizure.2017.01.004 .
doi: 10.1016/j.seizure.2017.01.004 pubmed: 28226274
Yuan F, Gao Q, Jiang W. Prognostic scores in status epilepticus-a critical appraisal. Epilepsia. 2018;59(Suppl 2):170–5. https://doi.org/10.1111/epi.14483 .
doi: 10.1111/epi.14483 pubmed: 30159870
Rossetti AO, Logroscino G, Bromfield EB. A clinical score for prognosis of status epilepticus in adults. Neurology. 2006;66(11):1736–8. https://doi.org/10.1212/01.wnl.0000223352.71621.97 .
doi: 10.1212/01.wnl.0000223352.71621.97 pubmed: 16769951
Rossetti AO, Logroscino G, Milligan TA, Michaelides C, Ruffieux C, Bromfield EB. Status epilepticus severity score (STESS): a tool to orient early treatment strategy. J Neurol. 2008;255(10):1561–6. https://doi.org/10.1007/s00415-008-0989-1 .
doi: 10.1007/s00415-008-0989-1 pubmed: 18769858
Goyal MK, Chakravarthi S, Modi M, Bhalla A, Lal V. Status epilepticus severity score (STESS): a useful tool to predict outcome of status epilepticus. Clin Neurol Neurosurg. 2015;139:96–9. https://doi.org/10.1016/j.clineuro.2015.09.010 .
doi: 10.1016/j.clineuro.2015.09.010 pubmed: 26409183
Pacha MS, Orellana L, Silva E, et al. Role of EMSE and STESS scores in the outcome evaluation of status epilepticus. Epilepsy Behav. 2016;64(Pt A):140–2. https://doi.org/10.1016/j.yebeh.2016.09.036 .
doi: 10.1016/j.yebeh.2016.09.036 pubmed: 27741463
Aukland P, Lando M, Vilholm O, Christiansen EB, Beier CP. Predictive value of the status epilepticus severity score (STESS) and its components for long-term survival. BMC Neurol. 2016;16(1):213. https://doi.org/10.1186/s12883-016-0730-0 .
doi: 10.1186/s12883-016-0730-0 pubmed: 27816063
González-Cuevas M, Santamarina E, Toledo M, et al. A new clinical score for the prognosis of status epilepticus in adults. Eur J Neurol. 2016;23(10):1534–40. https://doi.org/10.1111/ene.13073 .
doi: 10.1111/ene.13073 pubmed: 27415411
Sutter R, Kaplan PW, Rüegg S. Independent external validation of the status epilepticus severity score. Crit Care Med. 2013;41(12):e475–9. https://doi.org/10.1097/CCM.0b013e31829eca06 .
doi: 10.1097/CCM.0b013e31829eca06 pubmed: 23982031
Leitinger M, Höller Y, Kalss G, et al. Epidemiology-based mortality score in status epilepticus (EMSE). Neurocrit Care. 2015;22(2):273–82. https://doi.org/10.1007/s12028-014-0080-y .
doi: 10.1007/s12028-014-0080-y pubmed: 25412806
Kang BS, Kim DW, Kim KK, et al. Prediction of mortality and functional outcome from status epilepticus and independent external validation of STESS and EMSE scores. Crit Care. 2016;20:25. https://doi.org/10.1186/s13054-016-1190-z .
doi: 10.1186/s13054-016-1190-z pubmed: 26812954
Wang P, Guan Y, Lin X, et al. Diagnostic value of status epilepticus severity score for survival conditions of patients with status epilepticus: a PRISMA-compliant systematic review and meta-analysis. Epilepsy Behav. 2018;82:104–10. https://doi.org/10.1016/j.yebeh.2018.02.033 .
doi: 10.1016/j.yebeh.2018.02.033 pubmed: 29604482
Leitinger M, Kalss G, Rohracher A, et al. Predicting outcome of status epilepticus. Epilepsy Behav. 2015;49:126–30. https://doi.org/10.1016/j.yebeh.2015.04.066 .
doi: 10.1016/j.yebeh.2015.04.066 pubmed: 26071999
Song YY, Lu Y. Decision tree methods: applications for classification and prediction. Shanghai Arch Psychiatry. 2015;27:130–5.
pubmed: 26120265
Shirali GA, Noroozi MV, Malehi AS. Predicting the outcome of occupational accidents by CART and CHAID methods at a steel factory in Iran. J Public Health Res. 2018;7:1361.
doi: 10.4081/jphr.2018.1361 pubmed: 30581805
Brigo F, Turcato G, Lattanzi S, et al. Machine-learning validation through decision-tree analysis of the epidemiology-based mortality score in status epilepticus. Epilepsia. 2022. https://doi.org/10.1111/epi.17372 .
doi: 10.1111/epi.17372 pubmed: 35869796
Leitinger M, Beniczky S, Rohracher A, et al. Salzburg consensus criteria for non-convulsive status epilepticus–approach to clinical application. Epilepsy Behav. 2015;49:158–63. https://doi.org/10.1016/j.yebeh.2015.05.007 .
doi: 10.1016/j.yebeh.2015.05.007 pubmed: 26092326
Leitinger M, Trinka E, Gardella E, et al. Diagnostic accuracy of the Salzburg EEG criteria for non-convulsive status epilepticus: a retrospective study. Lancet Neurol. 2016;15(10):1054–62. https://doi.org/10.1016/S1474-4422(16)30137-5 .
doi: 10.1016/S1474-4422(16)30137-5 pubmed: 27571157
Brophy GM, Bell R, Claassen J, et al. Guidelines for the evaluation and management of status epilepticus. Neurocrit Care. 2012;17(1):3–23. https://doi.org/10.1007/s12028-012-9695-z .
doi: 10.1007/s12028-012-9695-z pubmed: 22528274
Glauser T, Shinnar S, Gloss D, et al. Evidence-based guideline: treatment of convulsive status epilepticus in children and adults: report of the guideline committee of the American epilepsy society. Epilepsy Curr. 2016;16(1):48–61. https://doi.org/10.5698/1535-7597-16.1.48 .
doi: 10.5698/1535-7597-16.1.48 pubmed: 26900382
Minicucci F, Ferlisi M, Brigo F, et al. Management of status epilepticus in adults position paper of the Italian League against epilepsy. Epilepsy Behav. 2020;102:106675. https://doi.org/10.1016/j.yebeh.2019.106675 .
doi: 10.1016/j.yebeh.2019.106675 pubmed: 31766004
Hajian-Tilaki K. Receiver operating characteristic (ROC) curve analysis for medical diagnostic test evaluation. Caspian J Intern Med. 2013;4(2):627–35.
pubmed: 24009950
Park SH, Goo JM, Jo CH. Receiver operating characteristic (ROC) curve: practical review for radiologists. Korean J Radiol. 2004;5(1):11–8.
doi: 10.3348/kjr.2004.5.1.11 pubmed: 15064554
Turcato G, Zaboli A, Pfeifer N, et al. Decision tree analysis to predict the risk of intracranial haemorrhage after mild traumatic brain injury in patients taking DOACs. Am J Emerg Med. 2021;50:388–93.
doi: 10.1016/j.ajem.2021.08.048 pubmed: 34478944
Song YY, Lu Y. Decision tree methods: applications for classification and prediction. Shanghai Arch Psychiatry. 2015;27(2):130–5. https://doi.org/10.11919/j.issn.1002-0829.215044 .
doi: 10.11919/j.issn.1002-0829.215044 pubmed: 26120265
Shirali GA, Noroozi MV, Malehi AS. Predicting the outcome of occupational accidents by CART and CHAID methods at a steel factory in Iran. J Public Health Res. 2018;7(2):1361. https://doi.org/10.4081/jphr.2018.1361 .
doi: 10.4081/jphr.2018.1361 pubmed: 30581805
Towne AR, Pellock JM, Ko D, DeLorenzo RJ. Determinants of mortality in status epilepticus. Epilepsia. 1994;35(1):27–34. https://doi.org/10.1111/j.1528-1157.1994.tb02908.x .
doi: 10.1111/j.1528-1157.1994.tb02908.x pubmed: 8112254
Logroscino G, Hesdorffer DC, Cascino G, Annegers JF, Hauser WA. Short-term mortality after a first episode of status epilepticus. Epilepsia. 1997;38(12):1344–9. https://doi.org/10.1111/j.1528-1157.1997.tb00073.x .
doi: 10.1111/j.1528-1157.1997.tb00073.x pubmed: 9578531
Koubeissi M, Alshekhlee A. In-hospital mortality of generalized convulsive status epilepticus: a large US sample. Neurology. 2007;69(9):886–93. https://doi.org/10.1212/01.wnl.0000269791.96189.70 .
doi: 10.1212/01.wnl.0000269791.96189.70 pubmed: 17724291
Leitinger M, Trinka E, Giovannini G, et al. Epidemiology of status epilepticus in adults: a population-based study on incidence, causes, and outcomes. Epilepsia. 2019;60(1):53–62. https://doi.org/10.1111/epi.14607 .
doi: 10.1111/epi.14607 pubmed: 30478910
Logroscino G, Hesdorffer DC, Cascino G, Annegers JF, Hauser WA. Time trends in incidence, mortality, and case-fatality after first episode of status epilepticus. Epilepsia. 2001;42(8):1031–5. https://doi.org/10.1046/j.1528-1157.2001.0420081031.x .
doi: 10.1046/j.1528-1157.2001.0420081031.x pubmed: 11554890
Lattanzi S, Giovannini G, Brigo F, Orlandi N, Trinka E, Meletti S. Status epilepticus with prominent motor symptoms clusters into distinct electroclinical phenotypes. Eur J Neurol. 2021;28(8):2694–9. https://doi.org/10.1111/ene.14891 .
doi: 10.1111/ene.14891 pubmed: 33932068
Sutter R, Kaplan PW. The neurophysiologic types of nonconvulsive status epilepticus: EEG patterns of different phenotypes. Epilepsia. 2013;54(Suppl 6):23–7.
doi: 10.1111/epi.12269 pubmed: 24001065
Sutter R, Semmlack S, Kaplan PW. Nonconvulsive status epilepticus in adults - insights into the invisible. Nat Rev Neurol. 2016;12(5):281–93.
doi: 10.1038/nrneurol.2016.45 pubmed: 27063108
Sutter R. Are we prepared to detect subtle and nonconvulsive status epilepticus in critically Ill patients? J Clin Neurophysiol. 2016;33(1):25–31.
doi: 10.1097/WNP.0000000000000216 pubmed: 26840874
Kinney MO, Craig JJ, Kaplan PW. Hidden in plain sight: Non-convulsive status epilepticus—recognition and management. Acta Neurol Scand. 2017;136:280–92.
doi: 10.1111/ane.12732 pubmed: 28144933
Teasdale G, Jennett B. Assessment of coma and impaired consciousness A practical scale. Lancet. 1974;2(7872):81–4. https://doi.org/10.1016/s0140-6736(74)91639-0 .
doi: 10.1016/s0140-6736(74)91639-0 pubmed: 4136544
Lattanzi S, Giovannini G, Brigo F, Orlandi N, Trinka E, Meletti S. Clinical phenotypes within nonconvulsive status epilepticus. Epilepsia. 2021;62(9):e129–34. https://doi.org/10.1111/epi.16999 .
doi: 10.1111/epi.16999 pubmed: 34244997
Semmlack S, Kaplan PW, Spiegel R, et al. Illness severity scoring in status epilepticus-when STESS meets APACHE II, SAPS II, and SOFA. Epilepsia. 2019;60(2):189–200.
doi: 10.1111/epi.14623 pubmed: 30585317
Sutter R, Semmlack S, Opić P, et al. Untangling operational failures of the Status Epilepticus Severity Score (STESS). Neurology. 2019;92(17):e1948–56.
doi: 10.1212/WNL.0000000000007365 pubmed: 30918093
Yechoor N, Adeli A, Hafeez S. External validation of the epidemiology-based mortality score in status epilepticus in an American intensive care population. Epilepsy Res. 2018;148:32–6. https://doi.org/10.1016/j.eplepsyres.2018.10.001 .
doi: 10.1016/j.eplepsyres.2018.10.001 pubmed: 30342324
Huang TH, Lai MC, Chen YS, Huang CW. Status epilepticus mortality risk factors and a correlation survey with the newly modified STESS. Healthcare (Basel). 2021;9(11):1570.
doi: 10.3390/healthcare9111570 pubmed: 34828616

Auteurs

Francesco Brigo (F)

Department of Neurology, Hospital of Merano-Meran, Merano-Meran, Italy.

Gianni Turcato (G)

Department of Internal Medicine, Hospital of Santorso, Santorso, Italy.

Simona Lattanzi (S)

Neurological Clinic, Department of Experimental and Clinical Medicine, Marche Polytechnic University, Ancona, Italy.

Niccolò Orlandi (N)

Neurology Department, Azienda Ospedaliera-Universitaria di Modena, Modena, Italy.
Department of Biomedical, Metabolic, and Neural Sciences, University of Modena and Reggio-Emilia, Modena and Reggio-Emilia, Italy.

Giulia Turchi (G)

Neurology Department, Azienda Ospedaliera-Universitaria di Modena, Modena, Italy.

Arian Zaboli (A)

Department of Emergency Medicine, Hospital of Merano-Meran, Merano-Meran, Italy.

Giada Giovannini (G)

Neurology Department, Azienda Ospedaliera-Universitaria di Modena, Modena, Italy.
PhD Program in Clinical and Experimental Medicine, University of Modena and Reggio-Emilia, Modena, Italy.

Stefano Meletti (S)

Neurology Department, Azienda Ospedaliera-Universitaria di Modena, Modena, Italy. stefano.meletti@unimore.it.
Department of Biomedical, Metabolic, and Neural Sciences, University of Modena and Reggio-Emilia, Modena and Reggio-Emilia, Italy. stefano.meletti@unimore.it.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH